1.
Emerg Infect Dis
; 27(5)2021 05.
Artículo
en Inglés
| MEDLINE
| ID: mdl-33900908
RESUMEN
Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specific neutralizing antibodies were detected for 6 years postinfection.
